Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parissa Tabrizian

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 2, 2023
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortiumBrahma Natarajan, Parissa Tabrizian, Maarouf Hoteit, et al.
Clinical Transplantation|May 19, 2024
Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplantYuki Bekki, Chiara Rocha, Bryan Myers, et al.
The Lancet. Gastroenterology & Hepatology|May 26, 2022
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm studyEdward Kim, Alex Sher, Ghadi Abboud, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 2, 2023
European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular CarcinomaMarco Petrus Adrianus Wilhelmus Claasen, Dimitri Sneiders, Yannick Sebastiaan Rakké, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2017
Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs WestTian Yang, Parissa Tabrizian, Han Zhang, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 13, 2019
Renal Safety of Intravenous Ketorolac Use After Donor NephrectomyParissa Tabrizian, Massimo Giacca, Jake Prigoff, et al.
JHEP Reports : Innovation in Hepatology|February 6, 2025
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinomaParissa Tabrizian, Rebecca Marino, Sherrie Bhoori, et al.
Annals of Surgery|July 27, 2018
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection PoliciesKarim J Halazun, Parissa Tabrizian, Marc Najjar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 12, 2024
Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapyChiara Rocha, Joseph Di Norcia, Parissa Tabrizian, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 12, 2022
Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular CarcinomaLindsay B Young, Parissa Tabrizian, Jeffrey Sung, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 2, 2023
Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortiumBrahma Natarajan, Parissa Tabrizian, Maarouf Hoteit, et al.
Clinical Transplantation|May 19, 2024
Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplantYuki Bekki, Chiara Rocha, Bryan Myers, et al.
The Lancet. Gastroenterology & Hepatology|May 26, 2022
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm studyEdward Kim, Alex Sher, Ghadi Abboud, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 2, 2023
European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular CarcinomaMarco Petrus Adrianus Wilhelmus Claasen, Dimitri Sneiders, Yannick Sebastiaan Rakké, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2017
Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs WestTian Yang, Parissa Tabrizian, Han Zhang, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 13, 2019
Renal Safety of Intravenous Ketorolac Use After Donor NephrectomyParissa Tabrizian, Massimo Giacca, Jake Prigoff, et al.
JHEP Reports : Innovation in Hepatology|February 6, 2025
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinomaParissa Tabrizian, Rebecca Marino, Sherrie Bhoori, et al.
Annals of Surgery|July 27, 2018
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection PoliciesKarim J Halazun, Parissa Tabrizian, Marc Najjar, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 12, 2024
Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapyChiara Rocha, Joseph Di Norcia, Parissa Tabrizian, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 12, 2022
Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular CarcinomaLindsay B Young, Parissa Tabrizian, Jeffrey Sung, et al.
Pageof 14